All Asbestos Risk the Same?
Asbestos in the Environment
Asbestos Removal
Caregiver Support
Causes of Mesothelioma
Chemotherapy Resistance
Clinical Trials for Mesothelioma
Cured from Cancer?
Dietary Recommendations for Mesothelioma
DIY Asbestos Removal and Mesothelioma
Gene Therapy for Mesothelioma
Lung Cancer and Mesothelioma
Mesothelioma in Lymph Nodes
Need a Lawyer With Mesothelioma Diagnosis?
Peritoneal Mesothelioma
Protecting Yourself While Immunocompromised
Radiation Therapy for Mesothelioma
Risk with Asbestos Exposure and Smoking
Safety of Gene Therapy for Mesothelioma
Screening for Mesothelioma
Second Hand Asbestos Exposure and Mesothelioma
Signs and Symptoms of Mesothelioma
Support Groups for Mesothelioma
Surgery for Mesothelioma
Time from Exposure to Development of Mesothelioma
To Treat Mesothelioma or Not?
Too Late To Treat Mesothelioma?
Treatment for Mesothelioma
Websites for Mesothelioma

Biomarker Can Help Identify Pleural Mesothelioma

Oct 11, 2012 - Fibulin-3 levels in plasma and lung fluids can discriminate patients with mesothelioma from others with asbestos exposure or those whose lung effusions are unrelated to mesothelioma, according to a study published in the Oct. 11 issue of the New England Journal of Medicine.

I Wish You Knew

Caring for people with advanced lung cancer

View More

Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More